• Latest Posts

Top 5 Biotech Books to Enjoy your Summer on the Beach

A Tale of Love for UniQure and Bristol-Myers Squibb

Theravectys’ HIV Cure on the Road to Success

Vision specialist Gensight eyes a €90M IPO on NASDAQ

First Success for Imperial Innovations’ Gene Therapy in Cystic Fibrosis

German Viral Vector Producer SIRION pursues its American dream and opens in Boston


DNA Therapeutics presents positive results for its breakthrough Advanced Cancer Therapy

Selecta continues its tour around France with another collaboration

GSK sparks off the Gene Therapy resurgence

Live from Bio-Europe 2015: The product development challenges in the gene therapy field

Synpromics and UniQure, new Collaboration in Gene Therapy.

Theravectys: an Orphan Drug Designation for Its Lentiviral Vector-Based Therapeutic Vaccine